Sonia Trépanier

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19

Brian J. Ward, Philipe Gobeil, Annie Séguin et al. · Nature Medicine · 2021 · 300 citations · Full text

Immunology, Immunodominance, Covid-19 +18

Influenza virus‐like particles produced by transient expression in <i>Nicotiana benthamiana</i> induce a protective immune response against a lethal viral challenge in mice

Marc‐André D’Aoust, Pierre‐Olivier Lavoie, Manon Couture et al. · Plant Biotechnology Journal · 2008 · 277 citations

Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza

Nathalie Landry, Brian J. Ward, Sonia Trépanier et al. · PLoS ONE · 2010 · 273 citations · Full text

Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials

Brian J. Ward, Annie Séguin, Stéphane Pillet et al. · The Lancet · 2020 · 183 citations

Vaccination, Vaccine Safety, Vaccinology +12

A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults

Stéphane Pillet, Éric Aubin, Sonia Trépanier et al. · Clinical Immunology · 2016 · 151 citations · Full text

Immunology, Immunodominance, Strain Selection +21